Common Gout Medications Linked to Lower Risk of Heart Attack and Stroke

A large cohort study found that gout patients who lowered uric acid below 6 mg/dL in the first year had about a 9% lower five-year risk of major cardiovascular events.

The analysis covered more than 109,000 people starting urate-lowering therapy, including allopurinol, and was published in JAMA Internal Medicine.

The findings suggest that better-targeted gout treatment may reduce both painful flares and serious outcomes such as heart attack and stroke, if confirmed by further research.